• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Rheumatoid arthritis Market

    ID: MRFR/Pharma/14422-HCR
    100 Pages
    MRFR Team
    September 2025

    United States Rheumatoid arthritis Market Research Report to 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Rheumatoid arthritis Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    US Rheumatoid arthritis Market Summary

    The US Rheumatoid Arthritis market is projected to grow from 30.5 USD Billion in 2024 to 45.2 USD Billion by 2035.

    Key Market Trends & Highlights

    US Rheumatoid Arthritis Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 3.64 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 45.2 USD Billion, reflecting a robust growth trajectory.
    • In 2024, the market is valued at 30.5 USD Billion, indicating a strong foundation for future expansion.
    • Growing adoption of innovative treatment options due to increasing prevalence of rheumatoid arthritis is a major market driver.

    Market Size & Forecast

    2024 Market Size 30.5 (USD Billion)
    2035 Market Size 45.2 (USD Billion)
    CAGR (2025 - 2035) 3.64%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Key Companies in the US Rheumatoid arthritis Market market include

    FAQs

    What is the market size of the US Rheumatoid Arthritis Market in 2024?

    The US Rheumatoid Arthritis Market is expected to be valued at 20.19 USD billion in the year 2024.

    What is the projected market value of the US Rheumatoid Arthritis Market by 2035?

    By 2035, the US Rheumatoid Arthritis Market is expected to reach a valuation of 43.22 USD billion.

    What is the expected compound annual growth rate (CAGR) for the US Rheumatoid Arthritis Market from 2025 to 2035?

    The expected CAGR for the US Rheumatoid Arthritis Market from 2025 to 2035 is 7.166 percent.

    Which are the major players in the US Rheumatoid Arthritis Market?

    Major players in the market include Bristol Myers Squibb, Merck, Novartis, and AbbVie among others.

    What is the market value of Nonsteroidal anti-inflammatory drug type (NSAID) in 2024?

    The market value for Nonsteroidal anti-inflammatory drug type (NSAID) in 2024 is 6.0 USD billion.

    How much is the Steroids segment expected to be valued in 2035?

    The Steroids segment of the market is projected to be valued at 8.5 USD billion by 2035.

    What is the expected market value of Biologic agents in 2024?

    The Biologic agents segment is expected to be valued at 9.69 USD billion in the year 2024.

    What are the growth drivers for the US Rheumatoid Arthritis Market?

    Key growth drivers include increasing prevalence of rheumatoid arthritis and advancements in treatment options.

    What challenges does the US Rheumatoid Arthritis Market face?

    Challenges include high treatment costs and the side effects associated with long-term use of medications.

    What impact do emerging trends have on the US Rheumatoid Arthritis Market?

    Emerging trends such as personalized medicine and the development of novel therapies are shaping market dynamics positively.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials